Currently active clinical trials on the use of sunitinib for renal cell... | Download Scientific Diagram
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial - European Journal of Cancer
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma | NEJM
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial‡ - Annals of Oncology
Selected clinical trials investigating sunitinib in pancreatic... | Download Scientific Diagram
Identification of low-dose multidrug combinations for sunitinib-naive and pre-treated renal cell carcinoma | British Journal of Cancer
Sunitinib Does Not Accelerate Tumor Growth in Patients with Metastatic Renal Cell Carcinoma - ScienceDirect
Efficacy results of Phase III clinical trials comparing immune... | Download Scientific Diagram
First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial - European Urology
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma | NEJM
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial - European Journal of Cancer
Sunitinib in the treatment of renal cell carcinoma: an update on recent evidence | Semantic Scholar
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial - The Lancet Oncology
Sunitinib ongoing clinical trials. | Download Scientific Diagram
Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib - Annals of Oncology
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma | NEJM
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial - The Lancet Oncology
Clinical response to sunitinib as a multitargeted tyrosine-kinase inhi | OTT
Sunitinib: the antiangiogenic effects and beyond | OTT
Sunitinib for Gastrointestinal Stromal Tumors Clinical Trial | Power
Sunitinib ongoing clinical trials. | Download Scientific Diagram
Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials - European Journal of Cancer
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features | Journal of Clinical Oncology
ASCO GU 2018: Phase III Trial of Adjuvant Sunitinib in Patients with High-risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Selected clinical trials investigating sunitinib in pancreatic... | Download Scientific Diagram
